Sartorious/SRT3

€341.05

0.86%
-
1D1W1MYTD1YMAX

About Sartorious

Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. It operates through two segments: Bioprocess Solutions and Lab Products and Services. The Bioprocess Solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media, single-use bags for cell cultivation and storage of biopharmaceuticals, membrane adsorbers for purification in bioprocesses, and filter technology for clarification, among others. The Lab Products and Services segment provides instruments, consumables and services for laboratories, including laboratory balances, laboratory water systems for storage of purified water, electronic pipettes, filter systems for sample preparation and membrane filter systems for sterility testing of parenterals.

Ticker

SRT3

Sector

Healthcare

Trading on

XETRA

Industry

Scientific & Technical Instr.

CEO

Joachim Kreuzburg

Employees

14,614

Headquarters

Goettingen, Germany

Sartorious Metrics

BasicAdvanced
€22.71B
Market cap
89.60
P/E ratio
€3.01
EPS
0.44
Beta
€0.73
Dividend rate
0.27%
Dividend yield

What the Analysts think about Sartorious

Analyst Ratings

Majority rating from 2 analysts.
Buy

Price Targets

Average projection from 3 analysts.
3.6% upside
High €415.00
Low €320.00
€341.05
Current price
€353.33
Average price target

Sartorious Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
0.97% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
€849.8M
4.82%
Net income
€8.3M
-4.6%
Profit margin
0.97%
-9.35%

Sartorious Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 29.63%
QuarterlyAnnual
Q4 22
Q1 23
Q2 23
Q3 23
Q4 23
Actual
€2.24
€1.69
€1.26
€1.04
€0.95
Expected
€1.69
€2.19
€1.90
€1.29
€1.35
Surprise
32.54%
-22.65%
-33.68%
-19.38%
-29.63%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by ICE Data Services and Deutsche Börse. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell Sartorious stock

Buy or sell Sartorious stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing